News

SSRI affiliate has secured major federal funding to study why sickle cell disease patients experience pain so differently, and what that means for their care.The…

When Brandis Clayton Virgial and Halema Townsend first met through Zeta Phi Beta Sorority in 2023, they quickly bonded over their shared commitment to service.…

The U.S. Food and Drug Administration is reviewing an application from Vertex Pharmaceuticals seeking approval of Casgevy (exagamglogene autotemcel) for…

Building on its commitment to make insurance more accessible, especially for those affected by chronic or rare diseases, the insurer BNP Paribas Cardif is…

Sickle Cell Disease is included as an EHA 2026 disease-area keyword under non-malignant hematology, with relevant subtypes including Sickle Cell Pain Crises, Vaso-…

Mitapivat demonstrated statistically significant improvement in hemoglobin response compared with placebo, with rapid onset and durable effects New analyses…

MITAPIVAT significantly improved haemoglobin levels and markers of haemolysis in patients with sickle cell disease (SCD) in a Phase 3 trial, with additional…

Background:Sickle cell disease (SCD) is a progressive disorder characterized by acute pain crisis (APC), organ damage, and early mortality. Despite the (few)…

New Laws Will Expand Education, Training, Access, and Coordinated Care for Virginians with Sickle CellNEWPORT NEWS, VA — Governor Abigail Spanberger today signed a…

We are a specialist centre for the diagnosis and management of adults with inherited haemoglobin disorders including sickle cell disease, thalassaemia.Who we seeWe…